Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 55 results.

Thumbnail for Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis

CML - 115

Phenotype-Specific Safety Reporting Signals of Asciminib Versus Second- and Third-Generation Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A FAERS Disproportionality Analysis

Edward Mwarangu

Poster Presenter: Edward Mwarangu

Thumbnail for Cardiac Safety of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Real-World Propensity-Matched Comparison of Dasatinib, Nilotinib, and Imatinib

CML - 1166

Cardiac Safety of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Real-World Propensity-Matched Comparison of Dasatinib, Nilotinib, and Imatinib

Rukash Khan Niazi

Poster Presenter: Rukash Khan Niazi

Thumbnail for A Novel BCR::ABL1 I502T Mutation Associated With Acquired Asciminib Resistance in Chronic-Phase Chronic Myeloid Leukemia

CML - 1215

A Novel BCR::ABL1 I502T Mutation Associated With Acquired Asciminib Resistance in Chronic-Phase Chronic Myeloid Leukemia

Rahul Kumar Thakur

Poster Presenter: Rahul Kumar Thakur

Thumbnail for Early CD26? Leukemic Stem Cell Kinetics Can Predict Suboptimal Molecular Response and Switching TKIs during Chronic-Phase CML Therapy

CML - 1221

Early CD26? Leukemic Stem Cell Kinetics Can Predict Suboptimal Molecular Response and Switching TKIs during Chronic-Phase CML Therapy

Rudra Narayan Swain

Poster Presenter: Rudra Narayan Swain

Thumbnail for Divergent Trends in Chronic Myeloid Leukemia Mortality Associated with Cardiovascular Comorbidities in the United States (2018-2024): A CDC WONDER and GBD Analysis Highlighting Persistent Survivorship Risk

CML - 124

Divergent Trends in Chronic Myeloid Leukemia Mortality Associated with Cardiovascular Comorbidities in the United States (2018-2024): A CDC WONDER and GBD Analysis Highlighting Persistent Survivorship Risk

Tapan Giri

Poster Presenter: Tapan Giri

Thumbnail for Atherothrombotic adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia

CML - 1247

Atherothrombotic adverse effects of tyrosine kinase inhibitors in patients with chronic myeloid leukemia

Nadezhda Shnalieva

Poster Presenter: Nadezhda Shnalieva

Thumbnail for Rising Cardiovascular Comortality Among Decedents With Chronic Myeloid Leukemia in the United States, 2003-2024

CML - 1249

Rising Cardiovascular Comortality Among Decedents With Chronic Myeloid Leukemia in the United States, 2003-2024

Kristina Agustino

Poster Presenter: Kristina Agustino

Thumbnail for Long-Term Mortality Trends and Disparities in Chronic Myeloid Leukemia Among Older Adults in the United States: A 1999-2024 CDC WONDER Analysis

CML - 1331

Long-Term Mortality Trends and Disparities in Chronic Myeloid Leukemia Among Older Adults in the United States: A 1999-2024 CDC WONDER Analysis

Adeel Khan

Poster Presenter: Adeel Khan

Thumbnail for Cumulative Imatinib Exposure Is Associated With Renal but Not Skeletal Dysfunction in Chronic Phase CML

CML - 1344

Cumulative Imatinib Exposure Is Associated With Renal but Not Skeletal Dysfunction in Chronic Phase CML

AKSHAY MIDDINTI

Poster Presenter: AKSHAY MIDDINTI

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.